AU2024903018A0 - Compounds for cancer treatment - Google Patents

Compounds for cancer treatment

Info

Publication number
AU2024903018A0
AU2024903018A0 AU2024903018A AU2024903018A AU2024903018A0 AU 2024903018 A0 AU2024903018 A0 AU 2024903018A0 AU 2024903018 A AU2024903018 A AU 2024903018A AU 2024903018 A AU2024903018 A AU 2024903018A AU 2024903018 A0 AU2024903018 A0 AU 2024903018A0
Authority
AU
Australia
Prior art keywords
compounds
cancer treatment
cancer
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2024903018A
Inventor
Not Given
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nyrada Pty Ltd
Original Assignee
Nyrada Pty Ltd
Filing date
Publication date
Application filed by Nyrada Pty Ltd filed Critical Nyrada Pty Ltd
Publication of AU2024903018A0 publication Critical patent/AU2024903018A0/en
Priority to PCT/AU2025/051056 priority Critical patent/WO2026060487A1/en
Pending legal-status Critical Current

Links

AU2024903018A 2024-09-20 2024-09-20 Compounds for cancer treatment Pending AU2024903018A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2025/051056 WO2026060487A1 (en) 2024-09-20 2025-09-19 Compounds for cancer treatment

Publications (1)

Publication Number Publication Date
AU2024903018A0 true AU2024903018A0 (en) 2024-10-03

Family

ID=

Similar Documents

Publication Publication Date Title
AU2024220916A1 (en) Tricyclic compounds for the treatment of cancer
CA3264256A1 (en) Compounds for treating cancer
AU2024353718A1 (en) Compositions for treating cancer
CA3262155A1 (en) Compounds for treating cancer
AU2023419820A1 (en) Compounds and methods for treating cancer
AU2024903018A0 (en) Compounds for cancer treatment
AU2024225706A1 (en) Methods for treating breast cancer
AU2025901959A0 (en) Treatment for cancer
EP4226945A4 (en) Medicine for treating cancer
AU2024904045A0 (en) Compounds for the treatment of a complex cancer
AU2025903981A0 (en) Combination treatment for breast cancer
GB202508597D0 (en) Compounds for the treatment of cancer
CA3272243A1 (en) Combination therapy for treating cancer
CA3274939A1 (en) Methods for treating dll3-expressing cancer
CA3219579A1 (en) Methods for treating myc-amplified cancer
CA3271139A1 (en) Methods for treating cancer
HK40129670A (en) Methods for treating cancer
CA3270023A1 (en) Methods for treating cancer
HK40121918A (en) Combination therapy for treating cancer
HK40121856A (en) Combination therapy for treating cancer
CA3305948A1 (en) Compositions for treating cancer
CA3307092A1 (en) Combination therapy for cancer treatment
AU2024404739A1 (en) Psma-targeted radiopharmaceuticals for treatment of cancer
CA3296090A1 (en) Psma-targeted radiopharmaceuticals for treatment of cancer
AU2024298849A1 (en) Psma-targeted radiopharmaceuticals for treatment of cancer